Your browser doesn't support javascript.
loading
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19.
Infante, Marco; Pieri, Massimo; Lupisella, Santina; Mohamad, Ali; Bernardini, Sergio; Della-Morte, David; Fabbri, Andrea; De Stefano, Alberto; Iannetta, Marco; Ansaldo, Lorenzo; Crea, Angela; Andreoni, Massimo; Morello, Maria.
Afiliación
  • Infante M; Department of Systems Medicine & Diabetes Research Institute Federation (DRIF), University of Rome Tor Vergata, Rome, Italy.
  • Pieri M; Section of Diabetes and Metabolic Disorders, UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
  • Lupisella S; Cell Transplant Center, Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USA.
  • Mohamad A; Department of Experimental Medicine, Clinical Biochemistry and Molecular Biology, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Bernardini S; Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italy.
  • Della-Morte D; Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italy.
  • Fabbri A; Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italy.
  • De Stefano A; Department of Experimental Medicine, Clinical Biochemistry and Molecular Biology, Faculty of Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Iannetta M; Clinical Biochemistry Department, Tor Vergata University Hospital (PTV), Rome, Italy.
  • Ansaldo L; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Crea A; Department of Systems Medicine & Diabetes Research Institute Federation (DRIF), University of Rome Tor Vergata, Rome, Italy.
  • Andreoni M; Psychiatry Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Morello M; Volunteers Association, Tor Vergata University Hospital (PTV), Rome, Italy.
Curr Med Res Opin ; 39(4): 505-516, 2023 04.
Article en En | MEDLINE | ID: mdl-36749566
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido